ImmunoGen, Inc. - stock earnings
Stock symbol IMGN is outdated, potentially delisted? Maybe it is available on other exchange?
IMGN Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| April 26, 2024 AfterMarket | - / 0.0383000000 | - | - / 126.9 million | - |
IMGN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | 30.7 million USD | 113.4 million USD |
| 2023Q2 | -4.2 million USD | 83.2 million USD |
| 2023Q1 | -40.6 million USD | 49.9 million USD |
| 2022Q4 | -59.0 million USD | 41.2 million USD |
| 2022Q3 | -78.1 million USD | 15.4 million USD |
| 2022Q2 | -63.0 million USD | 14.2 million USD |
| 2022Q1 | -25.4 million USD | 38.1 million USD |
| 2021Q4 | -37.2 million USD | 28.0 million USD |
| 2021Q3 | -37.3 million USD | 9.2 million USD |
| 2021Q2 | -30.7 million USD | 16.9 million USD |
| 2021Q1 | -34.1 million USD | 15.7 million USD |
| 2020Q4 | 31.4 million USD | 85.8 million USD |
| 2020Q3 | -22.4 million USD | 18.2 million USD |
| 2020Q2 | -24.3 million USD | 15.0 million USD |
| 2020Q1 | -29.1 million USD | 13.3 million USD |
| 2019Q4 | 4.8 million USD | 44.9 million USD |
| 2019Q3 | -21.8 million USD | 13.3 million USD |
| 2019Q2 | -43.4 million USD | 15.5 million USD |
| 2019Q1 | -43.8 million USD | 8.6 million USD |
| 2018Q4 | -40.8 million USD | 13.8 million USD |
| 2018Q3 | -46.8 million USD | 10.9 million USD |
| 2018Q2 | -41.6 million USD | 9.3 million USD |
| 2018Q1 | -38.6 million USD | 19.8 million USD |
| 2017Q4 | -13.1 million USD | 39.4 million USD |
| 2017Q3 | -56.7 million USD | 8.5 million USD |
| 2017Q2 | -8.9 million USD | 39.0 million USD |
| 2017Q1 | -17.3 million USD | 28.5 million USD |
| 2016Q4 | -34.2 million USD | 13.8 million USD |
| 2016Q3 | -44.7 million USD | 7.7 million USD |
| 2016Q2 | -44.8 million USD | 7.4 million USD |
| 2016Q1 | -31.9 million USD | 19.7 million USD |
| 2015Q4 | -33.2 million USD | 18.0 million USD |
| 2015Q3 | -33.7 million USD | 14.9 million USD |
| 2015Q2 | -30.5 million USD | 12.6 million USD |
| 2015Q1 | -21.6 million USD | 11.4 million USD |
| 2014Q4 | 13.6 million USD | 48.3 million USD |
| 2014Q3 | -22.3 million USD | 13.2 million USD |
| 2014Q2 | -26.5 million USD | 5.7 million USD |
| 2014Q1 | -37.5 million USD | 6.9 million USD |
| 2013Q4 | 3.8 million USD | 30.1 million USD |
| 2013Q3 | -11.2 million USD | 17.2 million USD |
| 2013Q2 | -21.9 million USD | 3.8 million USD |
| 2013Q1 | -1.4 million USD | 25.0 million USD |
| 2012Q4 | -24.4 million USD | 2.6 million USD |
| 2012Q3 | -25.2 million USD | 4.1 million USD |
| 2012Q2 | -22.4 million USD | 3.0 million USD |
| 2012Q1 | -18.7 million USD | 3.3 million USD |
| 2011Q4 | -12.8 million USD | 7.6 million USD |
| 2011Q3 | -19.5 million USD | 2.5 million USD |
| 2011Q2 | -16.2 million USD | 6.5 million USD |
| 2011Q1 | -15.0 million USD | 5.2 million USD |
| 2010Q4 | -14.2 million USD | 4.2 million USD |
| 2010Q3 | -12.9 million USD | 3.4 million USD |
| 2010Q2 | -13.4 million USD | 4.4 million USD |
| 2010Q1 | -12.1 million USD | 3.3 million USD |
| 2009Q4 | -13.0 million USD | 3.1 million USD |
| 2009Q3 | -12.4 million USD | 3.1 million USD |
| 2009Q2 | -10.8 million USD | 4.3 million USD |
| 2009Q1 | -4.6 million USD | 8.2 million USD |
| 2008Q4 | -7.1 million USD | 9.3 million USD |
| 2008Q3 | -9.4 million USD | 6.1 million USD |
| 2008Q2 | -11.9 million USD | 4.5 million USD |
| 2008Q1 | -12.8 million USD | 14.6 million USD |
| 2007Q4 | -6.2 million USD | 9.8 million USD |
| 2007Q3 | -1.0 million USD | 11.4 million USD |
| 2007Q2 | -4.5 million USD | 8.5 million USD |
| 2007Q1 | -5.2 million USD | 9.8 million USD |
| 2006Q4 | -3.0 million USD | 12.1 million USD |
| 2006Q3 | -6.3 million USD | 7.8 million USD |
| 2006Q2 | -6.6 million USD | 8.4 million USD |
| 2006Q1 | -3.0 million USD | 9.4 million USD |
| 2005Q4 | -3.5 million USD | 6.6 million USD |
| 2005Q3 | -4.7 million USD | 7.8 million USD |
| 2005Q2 | -2.7 million USD | 7.4 million USD |
| 2005Q1 | -3.6 million USD | 10.2 million USD |
| 2004Q4 | -2.2 million USD | 9.0 million USD |
| 2004Q3 | -2.5 million USD | 9.0 million USD |
| 2004Q2 | 302259 USD | 9.3 million USD |
| 2004Q1 | -760000 USD | 7.6 million USD |
| 2003Q4 | -1.3 million USD | 5.2 million USD |
| 2003Q3 | -4.1 million USD | 3.9 million USD |
| 2003Q2 | -6.9 million USD | 1.3 million USD |
| 2003Q1 | -4.6 million USD | 1.5 million USD |
| 2002Q4 | -5.3 million USD | 2.5 million USD |
| 2002Q3 | -3.2 million USD | 2.3 million USD |
| 2002Q2 | -4.4 million USD | 1.7 million USD |
| 2002Q1 | -6.9 million USD | 1.2 million USD |
| 2001Q4 | -1.7 million USD | 1.5 million USD |
| 2001Q3 | -1.6 million USD | 1.4 million USD |
| 2001Q2 | -8.2 million USD | 1.3 million USD |
| 2001Q1 | -2.1 million USD | 752191 USD |
| 2000Q4 | -2.6 million USD | 626069 USD |
| 2000Q3 | -2.4 million USD | 1.8 million USD |
| 2000Q2 | 711472 USD | 4.7 million USD |
| 2000Q1 | -2.8 million USD | 1 USD |
| 1999Q4 | 100000 USD | 2.6 million USD |
| 1999Q3 | 1.8 million USD | 4.1 million USD |
| 1999Q2 | -300000 USD | 2.3 million USD |
| 1999Q1 | -700000 USD | 1.0 million USD |
| 1998Q4 | -1.6 million USD | 200000 USD |
| 1998Q3 | -1.6 million USD | 200000 USD |
| 1998Q2 | -2.5 million USD | 400000 USD |
| 1998Q1 | -1.5 million USD | 100000 USD |
| 1997Q4 | -1.8 million USD | 100000 USD |
| 1997Q3 | -1.8 million USD | 100000 USD |
| 1997Q2 | -1.9 million USD | 100000 USD |
| 1997Q1 | -2.3 million USD | 100000 USD |
| 1996Q4 | -2.5 million USD | 100000 USD |
| 1996Q3 | -2.3 million USD | 100000 USD |
| 1996Q2 | -5.2 million USD | 100000 USD |
| 1996Q1 | -2.7 million USD | 100000 USD |
| 1995Q4 | -5.0 million USD | 100000 USD |
| 1995Q3 | -3.6 million USD | 200000 USD |
| 1995Q2 | -4.0 million USD | 100000 USD |
| 1995Q1 | -4.3 million USD | 100000 USD |
| 1994Q4 | -6.1 million USD | 200000 USD |
| 1994Q3 | -5.5 million USD | 200000 USD |
| 1994Q2 | -6.6 million USD | 100000 USD |
| 1994Q1 | -6.1 million USD | 200000 USD |
| 1993Q4 | -6.2 million USD | 300000 USD |
| 1993Q3 | -4.9 million USD | 400000 USD |
| 1993Q2 | -5.2 million USD | 300000 USD |
| 1993Q1 | -4.6 million USD | 400000 USD |
| 1992Q4 | -5.0 million USD | 500000 USD |
| 1992Q3 | -3.8 million USD | 500000 USD |
| 1992Q2 | -4.2 million USD | 700000 USD |
| 1992Q1 | -4.2 million USD | 700000 USD |
| 1991Q4 | ? USD | 700000 USD |
| 1991Q3 | -3.8 million USD | 600000 USD |
| 1991Q2 | -2.9 million USD | 700000 USD |
| 1991Q1 | -2.9 million USD | 200000 USD |
| 1990Q4 | -2.8 million USD | 200000 USD |
| 1990Q3 | -200000 USD | 2.3 million USD |
| 1990Q2 | -2.5 million USD | 300000 USD |
| 1990Q1 | -2.1 million USD | 300000 USD |
| 1989Q4 | ? USD | 300000 USD |
| 1989Q3 | -1.6 million USD | 100000 USD |
| 1989Q2 | ? USD | 200000 USD |
| 1989Q1 | ? USD | 200000 USD |
| 1988Q4 | ? USD | 300000 USD |
| 1988Q3 | ? USD | 100000 USD |
IMGN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -73.5 million USD | 287.6 million USD |
| 2022 | -222.9 million USD | 108.8 million USD |
| 2021 | -222.9 million USD | 108.8 million USD |
| 2020 | -66.7 million USD | 132.3 million USD |
| 2019 | -122.1 million USD | 82.3 million USD |
| 2018 | -167.9 million USD | 53.8 million USD |
| 2017 | -96.0 million USD | 115.4 million USD |
| 2016 | -143.7 million USD | 60.0 million USD |
| 2015 | -60.7 million USD | 85.5 million USD |
| 2014 | -71.4 million USD | 59.9 million USD |
| 2013 | -72.8 million USD | 35.5 million USD |
| 2012 | -73.3 million USD | 16.4 million USD |
| 2011 | -58.3 million USD | 19.3 million USD |
| 2010 | -50.9 million USD | 13.9 million USD |
| 2009 | -31.9 million USD | 28.0 million USD |
| 2008 | -32.0 million USD | 40.2 million USD |
| 2007 | -19.0 million USD | 38.2 million USD |
| 2006 | -17.8 million USD | 32.1 million USD |
| 2005 | -11.0 million USD | 35.7 million USD |
| 2004 | -5.9 million USD | 26.0 million USD |
| 2003 | -20.0 million USD | 7.6 million USD |
| 2002 | -14.6 million USD | 5.9 million USD |
| 2001 | -15.3 million USD | 4.5 million USD |
| 2000 | -237560 USD | 11.2 million USD |
| 1999 | -4.1 million USD | 3.7 million USD |
| 1998 | -7.6 million USD | 600000 USD |
| 1997 | -9.0 million USD | 400000 USD |
| 1996 | -16.5 million USD | 500000 USD |
| 1995 | -19.9 million USD | 500000 USD |
| 1994 | -19.9 million USD | 500000 USD |
| 1993 | -23.7 million USD | 900000 USD |
| 1992 | -18.6 million USD | 1.7 million USD |
| 1991 | -15.3 million USD | 2.7 million USD |
| 1990 | -8.8 million USD | 3.4 million USD |
| 1989 | -8.3 million USD | 1.0 million USD |
| 1988 | -5.3 million USD | 800000 USD |
IMGN
Price: $31.24
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.28 USD
P/E Ratio: -111.54
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 2.7 million
Ebitda: -9.9 millionMarket Capitalization: 8.7 billion